April 2024

A listing of the individual articles included in the Jurisdiction E Medicare B News bulletin dated April 2024 is provided. Each article title functions as a hyperlink to a specific article.

paginationType regular
Articles Source
2023 ICD-10 Local Coverage Article (LCA) Updates
2024 Annual Update for the HPSA Bonus Payments CR13384
2024 Annual Update of HCPCS Codes for SNF CB Update CR13394
2024 Annual Update of Per-Beneficiary Threshold Amounts CR13371
2024 Annual Update to the Therapy Code List CR13341
2024 CPT/HCPCS Local Coverage Article (LCA) Updates
2024 CPT/HCPCS Local Coverage Article (LCA) Updates
ACM Questions and Answers - October 11, 2023
ACO Lookup Available in NMP
Additional Self-Service Requirements Effective February 5, 2024
Additional Self-Service Requirements Effective November 6, 2023
Advanced Beneficiary Notice of Non-coverage (ABN) and Appeals - Appeals Newsletter Part 7
AIF for Calendar Year (CY) 2024 and Productivity Adjustment - Rescinded CR13400
Allowing Audiologists to Provide Certain Diagnostic Tests Without a Physician Order - Revised CR13055
Ambulatory Surgical Center Payment System: January 2024 Update - Revised CR13481
Annual Participation Program
Annual Update of HCPCS Codes Used for Home Health Consolidated Billing Enforcement CR13295
Appropriate Use Criteria for Advanced Diagnostic Imaging: CY 2024 Update CR13485
April 2024 Quarterly ASP Medicare Part B Drug Pricing Files and Revisions to Prior Quarterly Pricing Files CR13492
Behavioral Health and Opioid Treatment Reminders
Beta Amyloid PET in Dementia and Neurodegenerative Disease CR13429
Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound (A58865) - R2 - Effective November 12, 2023
Billing and Coding: Artificial Hearts and Percutaneous Endovascular Cardiac Assist Procedures and Devices (A52966) Retirement - Effective November 1, 2023
Billing and Coding: Botulinum Toxin Types A and B Policy (A57185) - R6 - Effective October 1, 2023
Billing and Coding: Cataract Surgery in Adults (A57195) - R7 - Effective January 1, 2024
Billing and Coding: Dental Services (A59447) Retirement - Effective December 19, 2023
Billing and Coding: FDA Approved CLL Companion Diagnostic Test (A56009) Retirement - Effective March 30, 2023
Billing and Coding: Implantable Infusion Pumps for Chronic Pain (A55239) - R16 - Effective January 1, 2024
Billing and Coding: Intensity Modulated Radiation Therapy (IMRT) Article A58236 - Effective November 1, 2023
Billing and Coding: Minimal Residual Disease Testing for Hematologic Cancers (A58996) - R5 - Effective January 1, 2024
Billing and Coding: MolDX: DecisionDX-Melanoma (A57417) Retirement - Effective August 8, 2022
Billing and Coding: MolDX: Fragile X (A55241) - R6 - January 1, 2024
Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease (A57421) - R10 - Effective January 1, 2024
Billing and Coding: MolDX: Microsatellite Instability-High (MSI-H) and Mismatch Repair Deficient (dMMR) Biomarker for Patients with Unresectable or Metastatic Solid Tumors (A56103) - R4 - Effective January 1, 2024
Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58454) - R6- January 1, 2024
Billing and Coding: MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma (A59179) - R1 - Effective August 06, 2023
Billing and Coding: MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma (A59179) - R2 - Effective August 06, 2023
Billing and Coding: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer (A58718 ) - R3 - Effective March 12, 2024
Billing and Coding: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer (A58718) - R1 - Effective November 02, 2023
Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) (A57526) - R16- January 1, 2024
Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) (A57526) - R17 - Effective January 1, 2024
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720) - R12 - Effective October 01, 2023
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720) - R14 - Effective October 1, 2023
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720) - R15 - January 1, 2024
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720) - R16 - Effective April 17, 2022
Billing and Coding: MolDX: Molecular Testing for Solid Organ Allograft Rejection (A58168) - R6 - Effective February 29, 2024
Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors (A57901) - R6 - Effective January 1, 2024
Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies (A57891) - R7 - Effective January 1, 2024
Billing and Coding: MolDX: Pharmacogenomics Testing (A57384) - R11 - Effective October 01, 2023
Billing and Coding: MolDX: Pharmacogenomics Testing (A57384) - R13 - Effective January 25, 2024
— 50 Items per Page
Showing 1 - 50 of 175 results.